CA2156916A1 - Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans - Google Patents
Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humansInfo
- Publication number
- CA2156916A1 CA2156916A1 CA002156916A CA2156916A CA2156916A1 CA 2156916 A1 CA2156916 A1 CA 2156916A1 CA 002156916 A CA002156916 A CA 002156916A CA 2156916 A CA2156916 A CA 2156916A CA 2156916 A1 CA2156916 A1 CA 2156916A1
- Authority
- CA
- Canada
- Prior art keywords
- enteroviral
- formula
- compound
- humans
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2352793A | 1993-02-26 | 1993-02-26 | |
| US08/023,527 | 1993-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2156916A1 true CA2156916A1 (en) | 1994-09-01 |
Family
ID=21815649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002156916A Abandoned CA2156916A1 (en) | 1993-02-26 | 1994-02-23 | Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0686032A1 (enExample) |
| JP (1) | JPH08507062A (enExample) |
| AU (1) | AU691490B2 (enExample) |
| CA (1) | CA2156916A1 (enExample) |
| FI (1) | FI953980L (enExample) |
| HU (1) | HUT72490A (enExample) |
| IL (1) | IL108749A0 (enExample) |
| MX (1) | MXPA94001379A (enExample) |
| NZ (1) | NZ262794A (enExample) |
| TW (1) | TW284686B (enExample) |
| WO (1) | WO1994018960A1 (enExample) |
| ZA (1) | ZA941244B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210244716A1 (en) | 2018-10-03 | 2021-08-12 | Jyväskylän Yliopisto | Vemurafenib and salts thereof for use in the treatment of enteroviral infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8412799U1 (de) * | 1984-04-26 | 1984-10-31 | William Prym-Werke Kg, 5190 Stolberg | SB-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung fuer Fadenlegewerkzeuge wie Stricknadeln |
| EP0519702A1 (en) * | 1991-06-19 | 1992-12-23 | Schering Corporation | Orally active antiviral compounds |
-
1994
- 1994-02-23 AU AU62679/94A patent/AU691490B2/en not_active Ceased
- 1994-02-23 WO PCT/US1994/001605 patent/WO1994018960A1/en not_active Ceased
- 1994-02-23 ZA ZA941244A patent/ZA941244B/xx unknown
- 1994-02-23 IL IL10874994A patent/IL108749A0/xx unknown
- 1994-02-23 MX MXPA94001379A patent/MXPA94001379A/es not_active Application Discontinuation
- 1994-02-23 JP JP6519068A patent/JPH08507062A/ja active Pending
- 1994-02-23 CA CA002156916A patent/CA2156916A1/en not_active Abandoned
- 1994-02-23 HU HU9502494A patent/HUT72490A/hu unknown
- 1994-02-23 FI FI953980A patent/FI953980L/fi unknown
- 1994-02-23 EP EP94910114A patent/EP0686032A1/en not_active Ceased
- 1994-02-23 NZ NZ262794A patent/NZ262794A/en unknown
- 1994-02-24 TW TW083101586A patent/TW284686B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| FI953980A0 (fi) | 1995-08-24 |
| HUT72490A (en) | 1996-05-28 |
| ZA941244B (en) | 1994-08-23 |
| AU691490B2 (en) | 1998-05-21 |
| FI953980A7 (fi) | 1995-08-24 |
| NZ262794A (en) | 1997-03-24 |
| WO1994018960A1 (en) | 1994-09-01 |
| JPH08507062A (ja) | 1996-07-30 |
| MXPA94001379A (es) | 2011-09-26 |
| FI953980L (fi) | 1995-08-24 |
| TW284686B (enExample) | 1996-09-01 |
| EP0686032A1 (en) | 1995-12-13 |
| HU9502494D0 (en) | 1995-10-30 |
| AU6267994A (en) | 1994-09-14 |
| IL108749A0 (en) | 1994-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mahmoud et al. | Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19? | |
| Pahwa et al. | Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS | |
| Bearden et al. | Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy | |
| CN103153280B (zh) | 丙型肝炎病毒抑制剂的组合 | |
| Jackson et al. | Management of influenza: use of new antivirals and resistance in perspective | |
| Marker et al. | A trial of vidarabine for cytomegalovirus infection in renal transplant patients | |
| Ch'ien et al. | Antiviral chemotherapy and neonatal herpes simplex virus infection: a pilot study—experience with adenine arabinoside (ARA-A) | |
| EP2585067B1 (en) | Compound for the treatment of enteroviruses | |
| Wang et al. | In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus | |
| Kawashima et al. | A phase 3, randomized, double‐blind, placebo‐controlled study evaluating a single, patient‐initiated dose of amenamevir for recurrent herpes labialis | |
| CA2156916A1 (en) | Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans | |
| US5519028A (en) | Antiviral preparations | |
| KR20120112707A (ko) | 항-에이즈 제제로서 다중고리 화합물의 제약학적 용도 | |
| CN118615294A (zh) | 一种小分子化合物cl-255及其衍生物在抗rna病毒感染中的应用 | |
| CN102335171B (zh) | 一类n-(2-噻唑)苯甲酰胺衍生物的应用 | |
| Mellette et al. | Toxic reaction to para-aminosalicylic acid and isoniazid accompanied by leukopenia and atypical lymphocytosis | |
| Togo et al. | Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection | |
| Longson | The treatment of herpes encephalitis | |
| US20230213515A1 (en) | Drug and diagnostic combination system to identify and treat single-stranded rna viruses including coronaviruses and monkeypox | |
| Talsma et al. | Generalised Coxsackie A9 infection in a neonate presenting with pericarditis. | |
| Wunderli et al. | Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir, and sorivudine | |
| US20220409583A1 (en) | Treatment and Prevention of Dengue Disease | |
| O'Connell et al. | Development of antiviral agents for picornavirus infections | |
| CN113082028B (zh) | Alpelisib化合物在制备抗EV71病毒药物中的应用 | |
| Christen et al. | Hand-foot-and-mouth disease in a father and son |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |